跳至主要内容
临床试验/NCT01188213
NCT01188213已完成不适用

Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study

Assaf-Harofeh Medical Center0 个研究点开始时间: 2010年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
主要终点
WOMAC questionnaire

研究概览

简要总结

The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
  • radiographic confirmed knee OA according to the Kellgren & Lawrence scale

排除标准

  • acute septic arthritis
  • inflammatory arthritis
  • any other type of arthritis
  • history of knee buckling or recent knee injury
  • lack of physical or mental bility to perform or comply with the treatment procedure
  • diabetes mellitus
  • fibromyalgia or other chronic pain syndromes
  • concurrent anti-coagulant/anti-platelet drugs
  • arthroscopy or intra-articular injections in the previous 3 months

结局指标

主要结局

WOMAC questionnaire

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

相似试验